You are here: Industry Insights > COVID-19

News List

Early Treatment Can Stem the Tide of COVID-19 Hospitalizations and Deaths, States the Association of American Physicians & Surgeons (AAPS) prnewswire
January 04, 2021
A peer-reviewed updated summary of COVID-19 early-treatment best practices was published last Wednesday morning, in Reviews in Cardiovascular Medicine, an interdisciplinary scientific, open access journal.
FYR Diagnostics Partners with The State of Montana to Expand COVID-19 Testing prnewswire
January 04, 2021
?FYR Diagnostics, a Missoula-based biotech company, has executed a contract with the State of Montana that will increase statewide COVID-19 testing capacity and reduce the time patients must wait to receive results.
Early Multidrug COVID-19 Treatment Can Prevent Hospitalizations and Deaths, States Physicians for Civil Defense prnewswire
January 04, 2021
An international collaboration of physicians has just published an updated protocol for early at-home treatment of COVID-19, which recognizes the three stages of the disease.
FDI in brownfield pharma projects – Critical analysis expresspharma
January 04, 2021
The COVID-19 crisis has bought the pharma sector back to the limelight, and foreign investors are seeing India as a viable option for investments and setting up and developing their manufacturing bases.
Dry run for COVID-19 vaccine roll out in all States/UTs on January 2, 2021 expresspharma
January 04, 2021
The activity is proposed to be conducted in all state capitals in at least three session sites; Maharashtra and Kerala are likely to schedule the dry run in major cities other than their capital.
Lymphoma drug, pralatrexate outperforms remdesivir against COVID-19: Study expresspharma
January 04, 2021
However, this chemotherapy drug can prompt significant side effects so immediate use for COVID-19 patients is not guaranteed, said researchers.
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021 expresspharma
January 04, 2021
Mumbai-based Navin Saxena Research & Technology (NSRT) plans to start Phase II clinical trial of Eflornithine granules 2.5 gm for the treatment of moderate COVID-19 infection by the first week of January 2021.
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D expresspharma
January 04, 2021
The company will now be initiating Phase III clinical trial in around 30,000 volunteer.
Bausch Health's DEXAVEN (Dexamethasone Phosphate) Receives New Indication In Poland To Treat Patients With SARS-CoV-2 (COVID-19) prnewswire
December 31, 2020
Bausch Health Companies Inc., announced that the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland has granted an additional new indication for DEXAVEN (dexamethasone phosphate) solution for injection ...
Mologic Receives CE Mark Approval for COVID-19 Rapid Antigen Test americanpharmaceuticalreview
December 31, 2020
Mologic has announced its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM).